First new oral polio vaccine in quite a while Kumar Jeetendra | April 27, 2020 Stage 1 preliminary shows guarantee for fruition of slowed down annihilation exertion; offers exercises for COVID-19 immunization improvement Before being stopped because of the COVID-19 pandemic, a constant immunization crusade had almost prevailing with regards to annihilating polio from the world. Somewhere in the range of 2000 and 2017, the World Health Organization (WHO) assessed …
An antibody restricts infection by the SARS-CoV-2 in cells, researchers find Kumar Jeetendra | May 5, 2020 Specialists at Utrecht University, Erasmus Medical Center and Harbor BioMed (HBM) today announced that they have recognized a completely human monoclonal antibody that forestalls the SARS-CoV-2 (COVID-19) virus from infecting cultured cells. The disclosure, distributed online today in Nature Communications, is an underlying advance towards building up a completely human immune response to treat or …
Two medications show guarantee against COVID-19 Kumar Jeetendra | May 5, 2020 Korean analysts have screened 48 FDA-affirmed drugs against SARS-CoV-2, and found that two, that are as of now FDA-endorsed for different sicknesses, appear to be encouraging. The FDA endorsement for different utilizations would extraordinarily decrease the time expected to pick up FDA endorsement of utilization in COVID-19. The exploration is distributed in Antimicrobial Agents and …
“TOTAL ANTIBODY DETECTION ASSAY KIT” for COVID -19 launched in India by J.Mitra Kumar Jeetendra | June 17, 2020 New Delhi, 17th June 2020: J Mitra & Co. Pvt Ltd, India’s leading global MNC in the In-Vitro Diagnostics (IVD) industry has launched its state-of-the-art Covid-19 Test Kit in the Indian market. Based on the Double Sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] MICROLISA. It is a serology-based total …
Killing antibodies in the fight against COVID-19 Kumar Jeetendra | July 9, 2020 An important line of defence in the fight against the new Coronavirus SARS-CoV-2 may be that the formation of neutralising antibodies. These can eliminate the intruders and possess great potential for use for prevention and treatment of SARS-CoV-2 illness. A group of investigators headed by Prof. Florian Klein (Cologne University Hospital) and the German Center …
Anthony Fauci bullish on possibilities for US antibody, not stressed over China winning race Kumar Jeetendra | July 16, 2020 The top US expert on infectious diseases, Dr. Anthony Fauci, predicted on Wednesday that the country will fulfill its own objective of a coronavirus vaccine by the year end and has been unmoved by the possibility that China would arrive there . When there aren’t any warranties,”I’m well about the projected schedule,” Fauci told Reuters …
New mass spectrometry-based test recognizes coronavirus in wash arrangements of patients Kumar Jeetendra | July 16, 2020 Pharmacists in Martin Luther University Halle-Wittenberg (MLU) have succeeded in detecting small amounts of coronavirus SARS-CoV-2 utilizing mass spectrometry. Because of their own investigation , they used naturopathic remedies of COVID-19 patients. The publication method might supplement conventional tests. It’s undergoing developments and could be available as standard diagnostic tool for COVID-19 in the future. …
Execution of Covid-19 Antibody Tests Ranked Kumar Jeetendra | July 17, 2020 An peer-reviewed study by researchers in NSF International and also Novateur Ventures, Vancouver, British Columbia, Canada, found significant variability within the accuracy of now available covid-19 antibody tests.1 From the absence of experiments and effective therapeutics such as SARS-CoV-2 and also the associated covid-19 disorder, dependable antibody testing is sometimes a key section of general …
US signs contract with Pfizer for COVID-19 antibody dosages Kumar Jeetendra | July 22, 2020 Wellbeing and Human Services Secretary Alex Azar declared on Wednesday that the US has marked an agreement with Pfizer for conveyance in December of the initial 100 million dosages of a COVID-19 antibody the pharmaceutical organization is attempting to create. The US could purchase another 500 million portions under the understanding, Azar said. “Presently those …
Test mRNA-based COVID-19 immunization evokes defensive safe reactions in animals Kumar Jeetendra | July 25, 2020 Two injections of this vaccine were enough to induce robust immunity, completely preventing SARS-CoV-2 infection in mice. MRNA-based vaccines are all attractive options for protecting against SARS-CoV-2 because they may be quickly designed and manufactured at a huge scale within weeks. Moreover, preclinical studies have shown that mRNA-based vaccines cause potent and broadly protective immune …
Waterloo Technology profiles Compounds in blood of COVID-19 Sufferers Kumar Jeetendra | July 29, 2020 A world-leading University of Waterloo spinoff company, that decodes blood samples for potential treatments for illnesses such as cancer and COVID-19, is expanding operations with the support of a 5-million USD investment. Bin Ma, a University of Waterloo computer engineering professor who co-founded Rapid Novor at 2015, says that the company’s technologies is the most …
Harbour BioMed and Viva Biotech declare key coordinated effort to promote biotech new startups Kumar Jeetendra | August 1, 2020 HBM will combine its top Harbour Mice® stage H2L2 and its expertise in global research and development of innovative molecules, with Viva Biotech’s structure-based early phase drug discovery services. This complementary partnership will provide advanced biotech startups access to next generation technologies that create synergies to accelerate the route between ideation to merchandise. The incubated …
